Stimulating Results Signal a New Treatment Option for People Living With Painful Diabetic Neuropathy - PubMed (original) (raw)

Review

Stimulating Results Signal a New Treatment Option for People Living With Painful Diabetic Neuropathy

David G Armstrong et al. J Diabetes Sci Technol. 2023 Sep.

Abstract

Background: Painful diabetic neuropathy (PDN) is a progressive condition that deprives many patients of quality of life. With limited treatment options available, successful pain management can be difficult to achieve.

Methods: We reviewed results of recent data evaluating high frequency spinal cord stimulation (SCS).

Results: from the SENZA-PDN randomized clinical trial (NCT03228420), the largest such trial to date, demonstrated 10-kHz spinal cord stimulation substantially reduced PDN refractory to conventional medical management along with improvements in health-related quality-of-life measures that were sustained over 12 months. These data supported the recent U.S. Food & Drug Administration (FDA) approval for 10-kHz SCS in PDN patients and contributed to the body of evidence on SCS available to health care professionals managing the effects of PDN.

Conclusion: High frequency spinal cord simulation appears to hold promise in treatment of painful diabetic neuropathy. We look forward to future works in the literature that will further elucidate these promising findings.

Keywords: 10-kHz SCS; diabetes; high-frequency spinal cord stimulation; neuromodulation; painful diabetic neuropathy; randomized clinical trial.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr DGA has received consulting fees as scientific advisor for Nevro Corp. Dr GG has received speaker fees from Eli Lilly, Novo Nordisk, and Abbott Diabetes, and has received consulting fees as a member of the scientific advisory board for Nevro Corp. Assistance in medical writing for this manuscript was funded by Nevro Corp.

References

    1. Zakin E, Abrams R, Simpson DM. Diabetic neuropathy. Semin Neurol. 2019;39(5):560-569. -PubMed
    1. Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011;34(10):2220-2224. -PMC -PubMed
    1. Armstrong DG. The big picture: lower extremity complications of diabetes. Diabetic Foot J. 2015;18(3):1-2.
    1. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367-2375. -PubMed
    1. Alam U, Sloan G, Tesfaye S. Treating pain in diabetic neuropathy: current and developmental drugs. Drugs. 2020;80(4):363-384. -PubMed

Publication types

MeSH terms

LinkOut - more resources